RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 12-22
  • Why the execution drug shortage won't go away

    Why the execution drug shortage won't go away
    In a few weeks, the U.S. Supreme Court will hear Glossip vs. Gross, which examines the use of the drug midazolam in lethal injection executions. The case comes on the heels of an infamously gruesome 2014, a year that saw botched executions in Ohio,...
  • Johnson& Johnson beats Street 1Q forecasts

    Johnson & Johnson's first-quarter profit uncharacteristically fell 8.6 percent, hurt by sharply unfavorable exchange rates, a major divestiture and competition to its new hepatitis C drug. The results from the world's biggest maker of health care...
  • Antidepressants: a deadly treatment?

    Antidepressants: a deadly treatment?
    The crash of Germanwings Flight 9525, allegedly the intentional act of co-pilot Andreas Lubitz, and the deaths of all 150 people on board is indeed a tragedy. But some good may come out of it if it induces people to take another look at those substances...
  • Mylan makes bid for Irish drugmaker Perrigo for $29 billion

    Generic drugmaker Mylan has made a bid to buy the Dublin-based drugmaker Perrigo Co. in a deal valued at about $29 billion. Mylan offered $205 per share in cash and stock. The offer was contained in a letter delivered to Perrigo CEO Joseph Papa on Monday...
  • Hospira gets new FDA warning over facility in Italy

    Drug and medical device maker Hospira said Tuesday that it received a warning letter from the Food and Drug Administration following an inspection at a company factory in Italy. The company has received five warnings from the FDA in less than two years....
  • FDA: Hospira's corrective actions at Italy plant weren't enough

     FDA: Hospira's corrective actions at Italy plant weren't enough
    The Food and Drug Administration has warned Hospira that corrective actions the drugmaker made at an Italy facility weren't sufficient, the company disclosed Tuesday in a regulatory filing. The FDA in a March 31 letter said Hospira lacked written...
  • Mylan offers about $29B for rival generic drugmaker Perrigo

    In a deal that would combine two generic drugmakers that recently left the U.S. for Europe, Mylan says it wants to buy Perrigo for $205 per share, or $28.86 billion. Shares of both companies climbed to all-time highs on the news. If they combine, Mylan...
  • GNC allowed to sell herbal brand under deal with N.Y. attorney general

    GNC allowed to sell herbal brand under deal with N.Y. attorney general
    Nutritional supplement retailer GNC Holdings Inc. is cleared to sell some of its most popular products, including echinacea, ginseng and St. John’s Wort, under an agreement announced Monday with New York’s attorney general. State...
  • Step therapy encourages sticking to Rx: My Word

    A subject that is receiving attention from Florida legislators this session relates to the use of pharmaceuticals and how those prescription drugs are provided to patients. A topic of particular interest is step therapy, where patients are prescribed...
  • Horizon Pharma buying Hyperion for about $1.1 billion

    Irish firm Horizon Pharma is buying Hyperion Therapeutics for about $1.1 billion, gaining two treatments for genetic disorders. Dublin-based Horizon Pharma said Monday that it would pay $46 a share for the Brisbane, Calif., company, marking a 5.6%...
  • FDA questions evidence for lower-risk tobacco product

    U.S. health regulators have questions about the data submitted by tobacco maker Swedish Match in its bid to become the first company to market a smokeless tobacco product as less harmful than cigarettes. Food and Drug Administration scientists say they...